Saari W S, Halczenko W, Cochran D W, Dobrinska M R, Vincek W C, Titus D C, Gaul S L, Sweet C S
J Med Chem. 1984 Jun;27(6):713-7. doi: 10.1021/jm00372a002.
The (5-methyl-2-oxo-1,3- dioxol -4-yl)methyl and (5-tert-butyl-2-oxo-1, 3- dioxol -4-yl)methyl esters of 3-hydroxy-alpha-methyltyrosine (methyldopa) were prepared and evaluated as progenitors of the amino acid. 1H NMR experiments reveal that the esters are converted cleanly to methyldopa and the corresponding alpha-diketone at pH 7.4, with the 5-methyl derivative undergoing hydrolysis faster than the 5-tert-butyl analogue. Bioavailability studies in dogs show that the esters, particularly the 5-methyl derivative, yield significant plasma levels of methyldopa. Both esters are orally effective antihypertensive agents in spontaneously hypertensive (SH) rats. These studies indicate that (2-oxo-1,3- dioxol -4-yl)methyl esters are viable prodrugs for the latentiation of methyldopa.
制备了3-羟基-α-甲基酪氨酸(甲基多巴)的(5-甲基-2-氧代-1,3-二氧戊环-4-基)甲酯和(5-叔丁基-2-氧代-1,3-二氧戊环-4-基)甲酯,并将其作为该氨基酸的前体进行评估。1H NMR实验表明,在pH 7.4时,这些酯可顺利转化为甲基多巴和相应的α-二酮,5-甲基衍生物的水解速度比5-叔丁基类似物快。在犬类中的生物利用度研究表明,这些酯,尤其是5-甲基衍生物,可使甲基多巴在血浆中达到显著水平。两种酯在自发性高血压(SH)大鼠中均为口服有效的抗高血压药物。这些研究表明,(2-氧代-1,3-二氧戊环-4-基)甲酯是使甲基多巴潜伏化的可行前药。